PubmedID,Title,Publication Date,Non-academic Authors,Company Affiliations,Corresponding Email
40733695,Pre-Vaccination Immune Profiles and Responsiveness to Innate Stimuli Predict Reactogenicity and Antibody Magnitude Following mRNA Vaccination.,2025-Jul-01,Emilie Goguet; Emily Samuels Darcey; Simon Pollett; John H Powers,"The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD 20814, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD 20814, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD 20814, USA.; Clinical Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.",N/A
40712320,2024-2025 BNT162b2 COVID-19 vaccine effectiveness in non-immunocompromised adults: mid-season estimates from vaccine registries in two states linked to administrative claims.,2025-Jul-24,Kathleen M Andersen; Tara Ahi; Jazmine S Mateus; Tiange Yu; Anan Zhou; Laura Puzniak,"Pfizer Inc., New York, NY, United States. Electronic address: Kathleen.andersen@pfizer.com.; Pfizer Inc., New York, NY, United States.; Genesis Research Group, Hoboken, NJ, United States.; Genesis Research Group, Hoboken, NJ, United States.; Genesis Research Group, Hoboken, NJ, United States.; Pfizer Inc., New York, NY, United States.",Kathleen.andersen@pfizer.com
40670524,The impact of vaccine booster doses on specific B- and T-lymphocyte dynamics in Thai healthcare personnel following COVID-19 vaccination.,2025-Jul-16,Wanitchaya Kittikraisak; Joshua A Mott,"Influenza Program, Thailand Ministry of Public Health - U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.; Influenza Program, Thailand Ministry of Public Health - U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.",N/A
40670372,Surveillance and follow up outcomes of myocarditis after mRNA COVID-19 vaccination in Australia.,2025-Jul-16,Abigail Cheung; Nicholas Cox; Michael Gold; Andrew Kelly; Sarah Khanlari; Sally Singleton; Gavin Wheaton,"Women's and Children's Health Network, Adelaide, South Australia, Australia.; Western Health, Victoria, Australia.; Women's and Children's Health Network, Adelaide, South Australia, Australia.; Women's and Children's Health Network, Adelaide, South Australia, Australia.; New South Wales Ministry of Health, St Leonards, NSW, Australia.; Australian Capital Territory Health Directorate, Canberra, ACT, Australia.; Women's and Children's Health Network, Adelaide, South Australia, Australia.",N/A
40669693,COVID-19 mRNA vaccine immune response to the addition of osteopathic manipulative treatment with lymphatic pumps: a randomized controlled trial.,2025-Jul-14,Julieanne P Sees; Laura J Peek; Gary Pestano,"Fellow of Osteopathic Medicine, the National Academy of Medicine, WA D.C., USA.; Biodesix, Inc., Louisville, CO, USA.; Biodesix, Inc., Louisville, CO, USA.",N/A
40660410,"A scoping review: the impact of nutritional status on the efficacy, effectiveness, and immunogenicity of COVID-19 vaccines.",2025-Jul-15,Slamet Riyanto; Ratih Puspitaningtyas Purbaningrum; Vitri Widyaningsih; Ratih Puspita Febrinasari; Ari Probandari,"Master of Public Health Program, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia.; Master of Public Health Program, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia.; Faculty of Medicine, Universitas Sebelas Maret, Surakarta, 57126, Indonesia.; Faculty of Medicine, Universitas Sebelas Maret, Surakarta, 57126, Indonesia.; Faculty of Medicine, Universitas Sebelas Maret, Surakarta, 57126, Indonesia.",N/A
40644466,Evaluation of adverse events and comorbidity exacerbation following the COVID-19 booster dose: A national survey among randomly-selected booster recipients.,2025,Dvora Frankenthal; Miri Zatlawi; Ziv Karni-Efrati; Lital Keinan-Boker; Aharona Glatman-Freedman; Michal Bromberg,"Ministry of Health, The Israel Center for Disease Control, Ramat Gan, Israel.; Ministry of Health, The Israel Center for Disease Control, Ramat Gan, Israel.; Ministry of Health, The Israel Center for Disease Control, Ramat Gan, Israel.; Ministry of Health, The Israel Center for Disease Control, Ramat Gan, Israel.; Ministry of Health, The Israel Center for Disease Control, Ramat Gan, Israel.; Ministry of Health, The Israel Center for Disease Control, Ramat Gan, Israel.",N/A
40639387,"Efficacy, immunogenicity, and safety of a next-generation mRNA-1283 COVID-19 vaccine compared with the mRNA-1273 vaccine (NextCOVE): results from a phase 3, randomised, observer-blind, active-controlled trial.",2025-Jul-07,Spyros Chalkias; Patrick Dennis; Dena Petersen; Krishnakumar Radhakrishnan; Leroy Vaughan; Reem Handforth; Alexandra Rossi; Rahnuma Wahid; Darin K Edwards; Jing Feng; Weiping Deng; Honghong Zhou; Elizabeth De Windt; Veronica Urdaneta; Yamuna Paila; Bethany Girard; Jacqueline Miller; Rituparna Das,"Moderna, Cambridge, MA, USA. Electronic address: Spyros.Chalkias@Modernatx.com.; DelRicht Research, New Orleans, LA, USA.; Noble Clinical Research, Tucson, AZ, USA.; Panthera Biopartners Rochdale, Rochdale, UK.; Clinical Research Partners, Richmond, VA, USA.; Panthera Biopartners Preston, Preston, UK.; Moderna, Cambridge, MA, USA.; Moderna, Cambridge, MA, USA.; Moderna, Cambridge, MA, USA.; Moderna, Cambridge, MA, USA.; Moderna, Cambridge, MA, USA.; Moderna, Cambridge, MA, USA.; Moderna, Cambridge, MA, USA.; Moderna, Cambridge, MA, USA.; Moderna, Cambridge, MA, USA.; Moderna, Cambridge, MA, USA.; Moderna, Cambridge, MA, USA.; Moderna, Cambridge, MA, USA.",Spyros.Chalkias@Modernatx.com
40634526,The role of intestinal microbiota in the humoral response to SARS-CoV-2 after mRNA-1273 vaccination.,2025-Jul-09,Abel Garcia-Diaz; Antonio José Cabrera-Serrano; Juan Sainz,"Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain.",N/A
40632835,Adenovirus and mRNA vaccines as well as mucosal boosting improve protective efficacy against influenza virus challenge in macaques.,2025-Jul-09,Catherine Jacob-Dolan; David Hope; Jinyan Liu; Alejandra Waller-Pulido; Brookelynne Verrette; Dalia N Cabrera-Barragan; Samuel J Nangle; Jana Fisher; Ninaad Lasrado; Liping Wang; Anthony Cook; Laurent Pessiant; Mark Lewis; Hanne Andersen; Markay Hopps; Ingrid L Scully; Pirada Suphaphiphat Allen; Annaliesa S Anderson; Dan H Barouch,"Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.; Bioqual, Rockville, MD 20850, USA.; Bioqual, Rockville, MD 20850, USA.; Bioqual, Rockville, MD 20850, USA.; Bioqual, Rockville, MD 20850, USA.; Pfizer Research and Development, Pfizer Inc., Pearl River, NY 10965, USA.; Pfizer Research and Development, Pfizer Inc., Pearl River, NY 10965, USA.; Pfizer Research and Development, Pfizer Inc., Pearl River, NY 10965, USA.; Pfizer Research and Development, Pfizer Inc., Pearl River, NY 10965, USA.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.",N/A
40610704,Kikuchi-Fujimoto in the light of the COVID-19: infection and vaccination. A systematic review.,2025-Aug,Nelson Luis Cahuapaza-Gutierrez; Cielo Cinthya Calderon-Hernandez; Tatiana Vanessa Villavicencio-Escudero,"Universidad Científica del Sur, Lima, Perú.; Universidad Científica del Sur, Lima, Perú.; Universidad Científica del Sur, Lima, Perú. tvillavicencio@cientifica.edu.pe.",tvillavicencio@cientifica.edu.pe
40610413,Immune correlates analysis of mRNA-1345 RSV vaccine efficacy clinical trial.,2025-Jul-03,Chong Ma; Jiejun Du; Lan Lan; Archana Kapoor; Gilberto Jimenez; Nancy Le Cam; Nina Lin; Frances Priddy; Sanjay Garg; Sonia K Stoszek; Christine A Shaw; Jaya Goswami; Eleanor Wilson; Rituparna Das; Honghong Zhou; Lingyi Zheng,"Moderna Inc, Cambridge, MA, USA.; Moderna Inc, Cambridge, MA, USA.; Moderna Inc, Cambridge, MA, USA.; Moderna Inc, Cambridge, MA, USA.; Spotlight Research Center LLC, Miami, FL, USA.; Moderna Inc, Cambridge, MA, USA.; Moderna Inc, Cambridge, MA, USA.; Moderna Inc, Cambridge, MA, USA.; Moderna Inc, Cambridge, MA, USA.; Moderna Inc, Cambridge, MA, USA.; Moderna Inc, Cambridge, MA, USA.; Moderna Inc, Cambridge, MA, USA.; Moderna Inc, Cambridge, MA, USA.; Moderna Inc, Cambridge, MA, USA.; Moderna Inc, Cambridge, MA, USA.; Moderna Inc, Cambridge, MA, USA. lingyi.zheng@modernatx.com.",lingyi.zheng@modernatx.com
40602349,Accomplishments and challenges in developing improved influenza vaccines: An evaluation of three years of progress toward the milestones of the influenza vaccines research and development roadmap.,2025-Jul-01,Julia T Ostrowsky; Natalie C Vestin; Angela J Mehr; Angela K Ulrich; Lauren Bigalke; Joseph S Bresee; Martin H Friede; Keith P Klugman; Usman N Nakakana; Tian Yun Wang; Charlotte L Weller; Michael T Osterholm; Eve M Lackritz; Kristine A Moore,"Center for Infectious Disease Research and Policy, C315 Mayo Memorial Building, MMC 263, 420 Delaware Street, SE, Minneapolis, MN 55455. 612-626-6770, United States of America. Electronic address: jto@umn.edu.; Center for Infectious Disease Research and Policy, C315 Mayo Memorial Building, MMC 263, 420 Delaware Street, SE, Minneapolis, MN 55455. 612-626-6770, United States of America.; Center for Infectious Disease Research and Policy, C315 Mayo Memorial Building, MMC 263, 420 Delaware Street, SE, Minneapolis, MN 55455. 612-626-6770, United States of America.; Center for Infectious Disease Research and Policy, C315 Mayo Memorial Building, MMC 263, 420 Delaware Street, SE, Minneapolis, MN 55455. 612-626-6770, United States of America.; Center for Infectious Disease Research and Policy, C315 Mayo Memorial Building, MMC 263, 420 Delaware Street, SE, Minneapolis, MN 55455. 612-626-6770, United States of America.; The Task Force for Global Health, Atlanta, GA, USA.; World Health Organization, Geneva, Switzerland.; The Gates Foundation, Seattle, Washington, USA.; The Gates Foundation, Seattle, Washington, USA.; Wellcome Trust, London, United Kingdom.; Wellcome Trust, London, United Kingdom.; Center for Infectious Disease Research and Policy, C315 Mayo Memorial Building, MMC 263, 420 Delaware Street, SE, Minneapolis, MN 55455. 612-626-6770, United States of America.; Center for Infectious Disease Research and Policy, C315 Mayo Memorial Building, MMC 263, 420 Delaware Street, SE, Minneapolis, MN 55455. 612-626-6770, United States of America.; Center for Infectious Disease Research and Policy, C315 Mayo Memorial Building, MMC 263, 420 Delaware Street, SE, Minneapolis, MN 55455. 612-626-6770, United States of America. Electronic address: kamoore@umn.edu.",kamoore@umn.edu
